Skip to content

Study on the effect of intravenous lidocaine on general anesthesia

Study on the effect of intravenous lidocaine on general anesthesia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069112
Enrollment
Unknown
Registered
2023-03-07
Start date
2023-03-09
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of general anesthesia

Interventions

L group:Intravenous infusion of lidocaine 1-2 mg/kg/h
C group:The same volume of normal saline was transfused

Sponsors

First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective general anesthesia; 2. Age: =18 years old; 3. Body Mass index (BMI) : 18.5-28 kg/m2; 4.ASA classification: ?-?.

Exclusion criteria

Exclusion criteria: 1. Known allergy to local anesthetics such as lidocaine; 2. Patients with severe cardiovascular disease; 3. Patients with abnormal liver and kidney function; 4. Patients with cerebrovascular disease; 5. Patients with mental diseases; 6. Chronic use of opioids, benzodiazepines, NSaids or any drug that acts on the central nervous system, drug abuse/alcohol abuse, etc., in the previous 2 weeks; 7. Patients with respiratory tract infection two weeks before surgery.

Design outcomes

Primary

MeasureTime frame
Neuroelectrophysiological monitoring indexes (IONM electrode impedance, etc.);Body temperature (nasopharyngeal temperature, anal temperature, axillary temperature, etc.);Postoperative pharyngeal pain score;Time of first postoperative exhaust or defecation;

Secondary

MeasureTime frame
Hemodynamic parameters (blood pressure, heart rate, etc.);Respiratory mechanical parameter;Complication rate of each system;

Countries

China

Contacts

Public Contactzhijia Guo

Department of Anesthesiology, First Hospital of Shanxi Medical University

guozj11@163.com13834676473

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026